Active Ingredients
(in each extended-release tablet)
Fexofenadine HCl 180 mg
(in each extended-release tablet)
Pseudoephedrine HCl 240 mg
The following Structured Product Label (SPL) was submitted to the FDA by Chattem, Inc. for the product Allegra-d Allergy And Congestion (NDC 41167-4320). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Fexofenadine HCl 180 mg
(in each extended-release tablet)
Pseudoephedrine HCl 240 mg
Antihistamine
Nasal decongestant
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years of age and over | take 1 tablet with a glass of water every 24 hours on an empty stomach; do not take more than 1 tablet in 24 hours |
| children under 12 years of age | do not use |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
acetone, black iron oxide, cellulose acetate, colloidal silicon dioxide, copovidone, croscarmellose sodium, FD&C blue #1 aluminum lake, glycerol triacetate, hypromellose, isopropyl alcohol, magnesium stearate, microcrystalline cellulose, polyethylene glycol, propylene glycol, povidone, sodium chloride, talc, titanium dioxide, water
call toll-free 1-800-633-1610 or www.allegra.com
NDC 41167-4320-7
NON-DROWSY
Allegra-D®
ALLERGY & CONGESTION
fexofenadine HCl 180 mg/antihistamine
pseudoephedrine HCl 240 mg/nasal decongestant
Extended Release Tablets
15 Tablets
* Please review the disclaimer below.